February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
You might also be interested by
News
CellCarta Joins Olink™ Certified Service Provider Network in China
February 13, 2025
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More info